The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

Try the newly designed Company Pages!
Switch now

Sorry, an error occured retrieveing data for this security. Please refresh the page and try again.

Sorry, an error occured retrieveing data for this security. Please refresh the page and try again.

News

Financials & Calendars

Income Statement

  • Sales $2,290,820,000
  • Earnings $390,940,000
  • Return on Equity 18.78%

Cash Flow

  • Cash Flow --
  • Cash $461,850,000
  • Current Ratio 6.13

12 months ended Mar 31, 2014.

Trailing 12 month results shown above.
All data is in U.S. dollars.

Balance Sheet

  • Assets $3,260,390,000
  • Liabilities $1,049,140,000
  • Liabilities-to-Equity Ratio 0.47

Price Ratios

  • Price to Sales 15.00
  • Price to Book 15.54
  • Price to Cash Flow n/a

Event Calendar

Event Last   Next  
Earnings Aug 5 $2.33 Nov 4 $2.10
Surprises Aug 5 -18.88% n/a n/a
Dividends n/a n/a n/a n/a
Splits n/a -- n/a n/a

12 months ended Aug 22, 2014.

A look at major corporate events and financial announcements that are coming up.

Company Information

About the Company

Regeneron Pharmaceuticals Inc. is a biopharmaceutical company that discovers, develops, and intends to commercialize therapeutic drugs for the treatment of serious medical conditions. Regeneron's platform technologies include Targeted GenomicsTM, FunctionomicsTM, and Designer Protein TherapeuticsTM. Regeneron has drugs in clinical and preclinical development for the potential treatment of obesity, rheumatoid arthritis, cancer, allergies, asthma, amyotrophic lateral sclerosis, constipating conditions, ischemia, and other diseases and disorders. (PRESS RELEASE)

Related Securities
Symbol Type Latest % Chg

Officers

  • P. Roy Vagelos, M.D. Chairman of the Board
  • Leonard S. Schleifer, M.D., Ph President; C.E.O. & Dir
  • Company Type: n/a
  • Company Status: n/a
  • Full-time Employees: n/a
  • Incorporation: United States,
    n/a
  • Top 1000 Ranking: Profit: n/a
    Revenue: n/a
    Assets: n/a

Head Office

777 OLD SAW MILL RIVER RD
TARRYTOWN, NY

Phone: (914)-347-7000
Fax: (516)-8699001

dbujnicki@kimcorealty.com
www.kimcorealty.com

Ideas & Discussion

Live Discussion of REGN on StockTwits
The Globe and Mail has
updated our Company Pages
Switch to the newly designed Company Pages format today for a more in-depth look at the companies you're following and pages that are easier to navigate. If you prefer the old layout after trying the new Company Pages, you can switch back anytime.